ProMetic BioTherapeutics Immune Globulin Intravenous (PBT IVIG Protocol 2004C009G)
Two main purposes of the study: To see if serious bacterial infections occur less than once a year in each study subject. This will determine if study drug is effective. Also to find out if study drug is safe and tolerable for study subjects.